Business Wire

Projection Mapping Showcase of "YOASOBI / 'Idol’” Premiered Saturday, December 14!

20.1.2025 04:14:00 CET | Business Wire | Press release

Share

~ Over 450,000 Visitors Have Experienced "TOKYO Night & Light" ~

The Tokyo Metropolitan Government has been hosting year-round projection mapping displays at the iconic Tokyo Metropolitan Government Building (No. 1 Building). These displays use light and sound to create vibrant and diverse works of art, transforming the landmark into a new tourism resource that illuminates Tokyo’s nightscape. The event began in February of 2024 and has been visited by approximately 450,000 people to date.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250107191600/en/

YOASOBI / 'Idol’ (Photo: Business Wire)

Recently, a new projection mapping work featuring YOASOBI's globally acclaimed song "Idol" premiered on Saturday, December 14. The opening day saw a large number of visitors from both Japan and abroad, creating an exciting atmosphere befitting such a popular attraction.
Feedback from attendees included comments such as, "I came to Japan as a tourist, and after seeing the weekday version, I wanted to see the weekend version as well, so I came back," "This is the most powerful projection mapping I've ever seen -- it was truly moving," and "YOASOBI's new content had a retro vibe, which I really enjoyed. I don’t think you’d see something like this very often overseas.”

Visitors can enjoy projection mapping videos created by renowned domestic and international creators, who have been highly praised at international competitions. This event is quickly evolving into one of Tokyo's must-visit tourist attractions. With its exceptional artistry, cutting-edge technology, and world-class content, this "new nighttime tourism hotspot that lights up Tokyo's nights" is one to watch.

Overview of the Work | YOASOBI / "Idol"
The song "Idol" by YOASOBI, which gained widespread attention as the theme song for an anime, is a masterpiece that blends rhythmic and vibrant elements with themes of uncertainty and inner conflict. The projection mapping display brings the emotional nuances of this song to life, offering an immersive visual and auditory experience.

Creator: Yukihiro Oka (Japan)
* Please visit our website for the screening schedule.
https://tokyoprojectionmappingproject.jp/en/

About the song
YOASOBI’s hit song "Idol" broke records by surpassing 800 million cumulative streaming plays in the shortest time ever. It topped several major global charts, including the U.S. Billboard Global Chart “Global Excl. U.S.,” Apple Music’s “Top 100: Global,” and YouTube Music Charts TOP 100 Songs Global, setting unprecedented milestones in J-POP history.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250107191600/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces 24-Week Long-Term Data from Phase 3 TRuE-AD4 Trial of Opzelura® (ruxolitinib) Cream in Adults with Moderate Atopic Dermatitis7.5.2026 14:50:00 CEST | Press release

First presentation of Week 24 results from TRuE-AD4 study in adults with moderate atopic dermatitis (AD) who had an inadequate response, intolerance or contraindication to topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs)at the 2026 EADV SymposiumThe vast majority of patients achieving EASI50 at Week 8 and continuing double-blind, as needed treatment with Opzelura® (ruxolitinib) cream through Week 24 demonstrated disease control, with 84.3% achieving EASI75 (a ≥75% improvement in the Eczema Area and Severity Index score from baseline) and 70.6% achieving IGA-TS (Investigator’s Global Assessment Treatment Success)Data support Type-II variation application submitted for ruxolitinib cream 1.5% for the treatment of adults with moderate AD in the European Union (EU), feedback expected in 1H 2026 Incyte (Nasdaq:INCY) today announced final 24-week data from the Phase 3 TRuE-AD4 study evaluating the efficacy and safety of Opzelura® (ruxolitinib) cream in adults with mode

Rapid Medical™’s TIGERTRIEVER™ 13 Demonstrates Promising 90-Day Outcomes in DISTALS Trial, Reinforcing Pivotal Safety and Efficacy Findings7.5.2026 14:03:00 CEST | Press release

Full data presented at ESOC 2026 further strengthen the clinical evidence supporting TIGERTRIEVER™ 13 for the treatment of distal vessel occlusion stroke — a segment representing nearly half of all ischemic strokes Rapid Medical™, a leading developer of advanced stroke treatment devices, today announced full results from the DISTALS randomized clinical trial, presented at the 11th European Stroke Organisation Conference (ESOC) in Maastricht, Netherlands, showing that TIGERTRIEVER™ 13 can safely restore blood flow to the brain and may improve clinical outcomes in patients with distal and medium vessel occlusion (DMVO) stroke. These findings build on earlier results showing a threefold improvement in restoring blood flow compared with medical management alone (p<0.0001), with no cases of serious brain bleeding observed in the treatment group. “These results show we can now safely restore blood flow and suggest this will make a meaningful difference for the right patients,” said Jeffrey L

2 Million Downloads in Six Months: Tabelog’s Multilingual App Solves Critical Dining Pain Points for Travelers to Japan7.5.2026 14:00:00 CEST | Press release

“Eat Where Locals Eat” Making authentic Japanese dining experiences accessible to global travelers through instant reservations at over 70,000 restaurants nationwide. Tabelog (https://tabelog.com/en/), one of Japan’s largest (*1) restaurant search and reservation services operated by Kakaku.com, Inc., has announced that its multilingual smartphone app (iOS/Android) for travelers visiting Japan has reached 2 million downloads (*2). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507560248/en/ 2M+ Downloads in 6 Months. The app also ranked #1 in downloads among Restaurant Search Apps in Japan for International Travelers (*3) in Taiwan, Hong Kong, South Korea, and the U.S., reflecting its immense popularity among global visitors. Download URL: https://tabelog-tourists.onelink.me/3eEh/iqkkho9r The Trusted Choice for Global Travelers: Solving Two Major Dining Pain Points in Japan For years, international visitors to Japan have

Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development7.5.2026 14:00:00 CEST | Press release

Altasciences, a fully integrated drug development solution company, andCertara (Nasdaq: CERT), a global leader in model-informed drug development (MIDD), today announced a strategic partnership to accelerate early-phase development programs. Fewer than half of preclinical drug candidates successfully reach first-in-human trials. Failures are driven by toxicity, poor pharmacokinetics, lack of efficacy, and challenges translating results from animals to humans. Many of these risks can be mitigated through a fully integrated model-informed drug development approach. Building on Altasciences’ Acceleration Platform, the integration of Certara’s strategic drug development services and biosimulation technology enables sponsors to establish proof of mechanism earlier, design more efficient studies, and make informed go/no-go decisions with greater confidence. By embedding modeling insights and digital workflows directly into development execution, study designs are optimized, dosing strategies

FIFA and Fanatics Expand Wide-Ranging Relationship to Include Historic Exclusive Collectibles Agreement (Trading Cards, Stickers and Trading Card Games)7.5.2026 13:00:00 CEST | Press release

Partnership includes FIFA tournaments and events from 2031Agreement encompasses both physical and digital collectibles, and for the first time brings the player jersey patch program to international footballPre-match press conferences for the FIFA World Cup Final to take place at Fanatics Fest on Friday, 17 July 2026 In a landmark agreement expanding their already successful wide-ranging commercial relationship, FIFA and Fanatics have signed a long-term, exclusive collectibles licensing deal that features trading cards, stickers, and trading card games. The agreement, which will begin in full in 2031, covers both physical and digital collectibles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507105628/en/ An example of the product innovations that will be brought to fans under this new partnership is the highly sought-after player jersey patch program, including debut patches, which will be inserted into football tradin

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye